MILAAN & SAN MATEO, Calif.–(BUSINESS WIRE)–Dompé, een toonaangevend biofarmaceutisch bedrijf met activiteiten in Italië en de VS, heeft vandaag bekendgemaakt dat het door de Amerikaanse Food and Drug Administration (FDA) is geselecteerd om deel te ne…
Author: Business Wire
Dompés Programm zu NAION wird für richtungsweisendes FDA-Programm Commissioner’s National Priority Voucher ausgewählt
MAILAND & SAN MATEO, Calif.–(BUSINESS WIRE)–Dompé, ein führendes biopharmazeutisches Unternehmen mit Niederlassungen in Italien und den USA, gab heute bekannt, dass es von der US-amerikanischen Food and Drug Administration (FDA) für die Teilnahme am …
Le programme de Dompé dans le domaine de la NAION sélectionné pour le programme national prioritaire du commissaire de la FDA
MILAN & SAN MATEO, Calif.–(BUSINESS WIRE)–Dompé, une société biopharmaceutique de premier plan implantée en Italie et aux États-Unis, a annoncé aujourd’hui avoir été sélectionnée par la Food and Drug Administration (FDA) américaine pour participer au…
Seleccionan el programa de Dompé en NAION para el emblemático programa Acerca del programa piloto de Vales de Prioridad Nacional del Comisionado de la FDA
MILAN Y SAN MATEO, Calif.–(BUSINESS WIRE)–Dompé, una biofarmacéutica líder con operaciones en Italia y Estados Unidos, ha anunciado hoy que ha sido seleccionada por la Administración de Alimentos y Medicamentos de Estados Unidos (FDA) para participar…
Il programma di Dompé sulla NOIA-NA selezionato per il prestigioso programma Commissioner’s National Priority Voucher della FDA
MILANO & SAN MATEO, Calif.–(BUSINESS WIRE)–Dompé, un’azienda biofarmaceutica leader con sedi operative in Italia e negli Stati Uniti, oggi ha annunciato di essere stata selezionata dalla Food and Drug Administration (FDA) statunitense per partecipare…
Dompé's Program in NAION Selected for Landmark FDA Commissioner’s National Priority Voucher Program
MILAN & SAN MATEO, Calif.–(BUSINESS WIRE)–Dompé earns FDA Commissioner’s Priority Voucher to fast-track its NGF therapy for NAION, accelerating review of a potential vision-saving treatment.
STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following statement: Broadwoo…
Samsara Vision Expands U.S. and Puerto Rico Clinical Study Sites for the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT®)
FAR HILLS, N.J.–(BUSINESS WIRE)– #AMD–Samsara Vision Expands U.S. and Puerto Rico Clinical Study Sites for the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT®)
IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes
CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–IntrinsiQ® Specialty Solutions (IntrinsiQ), a leader in data analytic solutions, and part of Cencora, can now offer expanded data and insights for oncology, retina and other therapeutic areas. As part of this expansi…
Y.ora Vision Launches Following Licensing Agreement Between SERI and Eyexora Global to Advance Minimally Invasive Glaucoma Surgery
SINGAPORE–(BUSINESS WIRE)– #glaucoma–Y.ora Vision Launches Following Licensing Agreement Between SERI and Eyexora Global to Advance Minimally Invasive Glaucoma Surgery
Heru Surpasses 1 Million Eyes Tested, Cementing Leadership in AI-Powered Vision Diagnostics
MIAMI–(BUSINESS WIRE)– #automation–Heru, the leader in AI-powered vision diagnostics, today announced it has surpassed a landmark achievement of one million eyes tested on its wearable platform. This significant milestone underscores the company’s a…
Warby Parker to Announce Third Quarter 2025 Financial Results November 6, 2025
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the third quarter ended September 30, 2025 will be released before…
OcuSciences Secures EU CE Clearance and Expands European Presence with OcuMet Beacon Instruments
ANN ARBOR, Mich.–(BUSINESS WIRE)–OcuSciences, a medical device company developing advanced ocular imaging technologies to help clinicians better understand retinal dystrophies and other leading causes of blindness, today announced that it has receive…
PolyActiva to Present Advancements in Next-Generation Ocular Micro-Implant Technology at Eyecelerator® @ AAO 2025
FORT WORTH, Texas & MELBOURNE, Australia–(BUSINESS WIRE)–PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to improve outcomes for patients with ocular conditions, today announced that Michael Brubaker…
Broadwood Partners Comments on STAAR Surgical’s Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today commented on the recent Current Report on Form 8-K filed by STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) with the U.S. Securities and…
EyeCare Partners to Present Leading Research and Expertise at the American Academy of Ophthalmology (AAO) 2025 in Orlando
ST. LOUIS–(BUSINESS WIRE)– #elevatingeyecare–EyeCare Partners announced its participation in the American Academy of Ophthalmology (AAO) 2025, Friday, Oct. 17, through Monday, Oct. 20.
Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today that …
Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
LONDON & SEATTLE–(BUSINESS WIRE)– #InvestorConference–Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood,…
Tilak Healthcare Obtains Reimbursement for Odysight®, the First Remote Monitoring Solution in Ophthalmology, via the PECAN Progam
PARIS–(BUSINESS WIRE)–Tilak Healthcare, a pioneering company and leader in digital health for chronic eye disease monitoring, announces that it has received a positive opinion from the French National Health Authority (HAS) for the exceptional reimbu…